Errik Anderson | BiotechTV

top of page

At an R&D event hosted by the company in Kendall Square today, Alloy Therapeutics' CEO Errik Anderson talks the latest in science regarding bispecifics, TCR mimics, genetic medicines, and more

He described the discovery work that Alloy does with its client partners, and highlighted emerging areas of science. Plus, the importance...

Company News

Mar 25

BioVenture VoiCes Episode 9: Alloy Therapeutics & 82VS's Errik Anderson

He describes his career path and learnings from the tech industry, co-founding Adimab, the work that Alloy and 82VS do to support and...

BioVenture VoiCes

Dec 30, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page

At an R&D event hosted by the company in Kendall Square today, Alloy Therapeutics' CEO Errik Anderson talks the latest in science regarding bispecifics, TCR mimics, genetic medicines, and more

BioVenture VoiCes Episode 9: Alloy Therapeutics & 82VS's Errik Anderson

Follow BiotechTV

Sponsors

Sponsor Spotlight